Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.
Thank you. Please check your inbox to confirm.
U.S. regulators have authorized a COVID-19 vaccine booster for healthy children ages 5 to 11.
The White House COVID task force held a news briefing on March 23. This comes the same day that Moderna said it's COVID-19 vaccine works in babies, toddlers and preschoolers.
A Maryland hospital says the first person to receive a heart transplant from a pig has died.
The Food and Drug Administration had urged Pfizer and its partner BioNTech to apply for authorization of extra-low doses of its vaccine for the youngest children before clinical studies were finished. On Friday, the FDA reversed course.
A number of factors, including the vaccine you started with and when your last dose was, help determine when you qualify, according to recommendations issued Thursday by the Centers for Disease Control and Prevention.
After the FDA advisers give their recommendation, the agency itself will make an official decision on whether to authorize boosters. Then next week, a panel convened by the CDC will offer more specifics on who should get them.
Support Provided By: